Skip to main content

Table 1 Intervention parameters: vaccination coverage of 12-year olds, reduction in future HPV and intervention costs

From: Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program

Intervention

Vaccination coverage

Beta distribution for vaccination coverage

Reduction in HPV infection for central estimate of vaccination coverage only (95% uncertainty interval)

Vaccination costs (NZ$ 2011; SD as% of expected valued used for gamma distribution)

Females

Males

HPV6/11

HPV16/18

HPV6/11

HPV16/18

Intervention 1G: Girls only program as per NZ in 2011

Māori: 56%; assumed SD = 2%

alpha = 344, beta = 271

Māori: 75% (57% to 83%)

Māori: 49% (41% to 59%)

Māori: 75% (55% to 83%)

Māori: 47% (41% to 53%)

$760 (10%)

Non-Māori: 45%; assumed SD = 2%

alpha = 278, beta =340

Non-Māori: 67% (48% to 76%)

Non-Māori: 41% (33% to 50%)

Non-Māori: 66% (47% to 74%)

Non-Māori: 37% (32% to 43%)

[($113 vaccine + $141 administrative) × 3]

Intervention 2G: Enhanced uptake as per Australia with school-only delivery (girls only)

73% (no variation by ethnicity or deprivation level); assumed SD = 5%

alpha = 56.8, beta = 21.0

81% (64% to 88%)

63% (53% to 73%)

81% (65% to 88%)

61% (53% to 67%)

$716 (10%) [($113 vaccine + $126

administrative) × 3]

Intervention 1G + B: Adding boys to 1G

Māori: 56%; assumed SD = 2%

alpha = 8.14, beta = 1.86

Māori: 77% (59% to 85%)

Māori: 67% (53% to 79%)

Māori: 78% (58% to 88%)

Māori: 73% (63% to 83%)

$760 (10%)

 

Non-Māori: 45%; assumed SD = 2%

alpha = 8.09, beta = 1.90

Non-Māori: 70% (50% to 79%)

Non-Māori: 58% (45% to 71%)

Non-Māori: 71% (51% to 80%)

Non-Māori: 65% (54% to 75%)

[($113 vaccine + $141 administrative) × 3]

Intervention 2G + B: Adding boys to 2G

73%; assumed SD = 5%

alpha = 7.84, beta = 2.16

81% (67% to 89%)

78% (65% to 90%)

82% (68% to 89%)

85% (65% to 96%)

$716 (10%)

[($113 vaccine + $126 administrative) × 3]